Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-899,746
Closed -$14.1M 981
2021
Q4
$14.1M Buy
899,746
+83,440
+10% +$1.34M 0.03% 416
2021
Q3
$16M Buy
816,306
+123,884
+18% +$2.81M 0.04% 396
2021
Q2
$17.9M Sell
692,422
-616,161
-47% -$14.5M 0.04% 378
2021
Q1
$24.3M Sell
1,308,583
-52,986
-4% -$1.2M 0.06% 301
2020
Q4
$34.4M Buy
1,361,569
+67,904
+5% +$1.75M 0.08% 218
2020
Q3
$35.3M Buy
1,293,665
+261,205
+25% +$6.55M 0.09% 176
2020
Q2
$24.3M Buy
1,032,460
+129,154
+14% +$2.65M 0.07% 256
2020
Q1
$17.3M Buy
903,306
+611,406
+209% +$15.2M 0.05% 293
2019
Q4
$7.92M Buy
+291,900
New +$7.87M 0.02% 510

Other funds holding AFYA

Aberdeen Group's AFYA Position: Q1 2022 in Review

Aberdeen Group sold out of Afya (AFYA) in Q1 2022, closing a stake of 899,746 shares — an estimated $14.1M sold.

Aberdeen Group first reported a position in AFYA in Q4 2019 and held it in 9 quarters. The position peaked at $35.3M in Q3 2020. 53 funds tracked by Wall St. Rank hold AFYA as of Q1 2022.

  • Aberdeen Group reported no remaining Afya position as of Q1 2022 after selling out during the quarter.
  • Aberdeen Group sold 899,746 Afya shares in Q1 2022, an estimated $14.1M.
  • Aberdeen Group first reported a position in Afya in Q4 2019 and held it in 9 quarters.
  • Aberdeen Group's Afya position peaked at $35.3M in Q3 2020.
  • 53 funds tracked by Wall St. Rank held Afya as of Q1 2022.

Based on Aberdeen Group's 13F filing for Q1 2022, filed 4 May 2022.